HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?

J Clin Oncol. 2004 Feb 1;22(3):568-9. doi: 10.1200/JCO.2004.99.085.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Chemotherapy, Adjuvant
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Premenopause
  • Prognosis
  • Receptor, ErbB-2 / metabolism*
  • Receptors, Estrogen / metabolism*
  • Tamoxifen / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Tamoxifen
  • Receptor, ErbB-2